rBio https://validator.w3.org/feed/docs/rss2.html blog Judith Shizuru, MD <br> <br> Director Marcela Huertas <br> <br> Director Deenadayalan Bakthavatsalam, Ph.D, MBA, CSSBB <br> CSO Cameron Owen, MS, MHA <br> <br> CEO/Chairman Charles Clark, MBA, CSM, PMC-III <br> <br> COO Harry Ramos <br> <br> CEO/Chairman Product Stuart Douglass <br> <br> Director Debanjan Dhar, Ph.D Home Houston startup completes testing, prepares biosimilar insulin drug for clinical trials A Startup Has Unlocked a Way to Make Cheap Insulin California-founded biotech startup relocates to join Houston’s emerging bioeconomy Houston A Growing Hub for Biotech News rBIO Achieves Crucial Milestone on Mission to Lower the Cost of Insulin by 30% rBIO Hits Key Lab Milestone with Synthetic Production of Insulin rBIO Launches with Technology to Hyper-Produce Insulin Cost-Effectively, at Scale Scaling insulin production with Cameron Owen, CEO/co-Founder of rBio rBIO Succeeds in Biomanufacturing Insulin Contact Us rBIO Completes Analytical Characterizations of R-biolin, Readies Biosimilar Insulin Drug for Clinical Trial Sergej Djuranovic, Ph.D About Us Elementor #3368 Home -03 Privacy Policy Terms of use Home 02 Journal Article Why Choose Us? Testimonials Team Member Help Faqs Sample Page Service Page widget3 widget widget2 My account Shop Cart Checkout Sample Page Careers Page